1910 Taubman Center, 1500 E. Medical Center Dr.
Ann Arbor, MI 48109
Available to mentor
Dr. Mio Nakamura is a board-certified dermatologist and an Assistant Professor of Dermatology. She provides medical dermatology diagnosis and treatment to patients of all ages within in our medical dermatology outpatient clinics. Dr. Nakamura maintains a strong interest in clinical research and serves as the Director of the Program for Clinical Research in Dermatology (PCRiD) in the department. In this role, she oversees patient recruitment and participation in clinical and translational studies.
Dr. Nakamura is a graduate of Wayne State University School of Medicine. Following graduation, she completed her transitional year internship at St. Joseph Mercy Health System in Ann Arbor, MI, and a Psoriasis and Clinical Research Fellowship in the Department of Dermatology at the University of California San Francisco, in San Francisco, CA. Dr. Nakamura obtained her Masters of Science in Clinical Research Design and Statistical Analysis at the University of Michigan School of Public Health. She completed her dermatology residency at the U-M Department of Dermatology, where she served as co-chief resident in her final year. Dr. Nakamura joined the U-M dermatology faculty in September 2021.
-
Chief ResidentUniversity of Michigan, Dermatology, 2021
-
ResidentUniversity of Michigan, Dermatology, 2021
-
FellowUniversity of California, San Francisco, Dermatology, 2017
-
Transitional YearSt Joseph Mercy Hospital, Ann Arbor, 2015
-
MSUniversity of Michigan School of Public Health, Ann Arbor, 2019
-
MDWayne State University School of Medicine, Detroit, 2014
-
BSUniversity of Michigan, Ann Arbor, 2010
Dr. Nakamura's research interests include conducting clinical trials to improve diagnosis and treatment of chronic inflammatory skin conditions such as psoriasis, atopic dermatitis, and pruritus, and autoimmune conditions such as cutaneous lupus and dermatomyositis.
-
Ma F, Tsou P-S, Gharaee-Kermani M, Plazyo O, Xing X, Kirma J, Wasikowski R, Hile GA, Harms PW, Jiang Y, Xing E, Nakamura M, Ochocki D, Brodie WD, Pillai S, Maverakis E, Pellegrini M, Modlin RL, Varga J, Tsoi LC, Lafyatis R, Kahlenberg JM, Billi AC, Khanna D, Gudjonsson JE. Nat Commun, 2024 Jan 3; 15 (1): 210Journal ArticleSystems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.
DOI:10.1038/s41467-023-44645-6 PMID: 38172207 -
Greene RK, Gangidi S, Zhao R, Nelson JM, Harms K, Nakamura M. Pediatr Dermatol, 2024 41 (4): 660 - 666.Journal ArticleThe relationship between acrochordons, obesity, and metabolic syndrome in the pediatric population: A retrospective cohort study.
DOI:10.1111/pde.15639 PMID: 38684337 -
Schlessel M, Nakamura M, Wang F. Clin Exp Dermatol, 2024 Apr 23; 49 (5): 491 - 496.Journal ArticlePositive perceptions of virtual didactics during the COVID-19 pandemic: a survey of dermatology residents' satisfaction, perception of efficacy and preferences.
DOI:10.1093/ced/llad435 PMID: 38060687 -
Nakamura M. 2024 Mar 9;PresentationY-GRAPPA Update.
-
Nakamura M. 2024 Mar 8;PresentationPersonality Disorders in Dermatology.
-
van Straalen KR, Ma F, Tsou P-S, Plazyo O, Gharaee-Kermani M, Calbet M, Xing X, Sarkar MK, Uppala R, Harms PW, Wasikowski R, Nahlawi L, Nakamura M, Eshaq M, Wang C, Dobry C, Kozlow JH, Cherry-Bukowiec J, Brodie WD, Wolk K, Uluçkan Ö, Mattichak MN, Pellegrini M, Modlin RL, Maverakis E, Sabat R, Kahlenberg JM, Billi AC, Tsoi LC, Gudjonsson JE. J Clin Invest, 2024 Feb 1; 134 (3):Journal ArticleSingle-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa.
DOI:10.1172/JCI169225 PMID: 38051587 -
Gangidi SV, Greene RK, Olsen E, Jackson S, Nakamura M. Int J Womens Dermatol, 2024 Oct; 10 (3): e159Journal ArticleEfficacy of spironolactone in treating hidradenitis suppurativa in women of childbearing age: a single-center retrospective analysis.
DOI:10.1097/JW9.0000000000000159 PMID: 38957411 -
Ma F, Gharaee-Kermani M, Tsoi LC, Plazyo O, Chaskar P, Harms P, Patrick MT, Xing X, Hile G, Piketty C, Lazzari A, Van Delm W, Maverakis E, Nakamura M, Modlin RL, Kahlenberg JM, Billi AC, Julia V, Krishnaswamy JK, Gudjonsson JE. J Allergy Clin Immunol, 2024 Jan; 153 (1): 146 - 160.Journal ArticleSingle-cell profiling of prurigo nodularis demonstrates immune-stromal crosstalk driving profibrotic responses and reversal with nemolizumab.
DOI:10.1016/j.jaci.2023.07.005 PMID: 37506977